Rennova Health (RNVA) Stock Price, News & Analysis

Rennova Health saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 2,934,100 shares, an increase of 186.4% from the February 29th total of 1,024,600 shares. Based on an average trading volume of 109,878,000 shares, the short-interest ratio is currently 0.0 days.
View Rennova Health's Short Interest.

Rennova Health, Inc. (OTCMKTS:RNVA) posted its quarterly earnings data on Tuesday, August, 14th. The company reported $2,500,000,000.00 EPS for the quarter. The business earned $3.29 million during the quarter. Rennova Health had a negative trailing twelve-month return on equity of 8.49% and a net margin of 11.61%.

Rennova Health's stock reverse split on the morning of Wednesday, March 16th 2022. The 1-10000 reverse split was announced on Wednesday, March 16th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, March 16th 2022. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some companies that other Rennova Health investors own include Neovasc (NVCN), Himax Technologies (HIMX), Precipio (PRPO), LadRx (CYTR), Heat Biologics (HTBX), Biopharmx (BPMX), Delcath Systems (DCTHD), Immune Pharmaceuticals (IMNP),

Shares of RNVA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.